BioStock published an article on 17 December 2020 about Follicum, which can be read in full below. A productive 2020 for Follicum is capped off by the completion of patient recruitment for its phase II hair growth study for determining the best dose and treatment duration of candidate FOL-005. BioStock spoke with Follicum’s CEO Jan […]
On 25 November 2020, Aktiespararna published their analysis of Follicum on their website. The analysis can also be read on Follicum’s webpage. Read the analysis at Aktiespararna.se For further information, please contact: Jan Alenfall – CEO, Follicum AB Telephone: +46 (0)709 31 51 15 Email: info@follicum.com About Follicum AB Follicum AB (Spotlight: FOLLI) develops drugs […]
BioStock published an article on 2 November 2020 about Follicum, which can be read in full below. Last week, biotech company Follicum announced a directed share issue of SEK 36.6 million to a number of selected investors. The funds will be used to bring the ongoing phase II trial in hair loss across the finish […]
BioStock published an article on 9 October 2020 about Follicum, which can be read in full below. Alopecia patients have very few treatment options available to them. Those that exist are often ineffective and come with a multitude of side effects, and they mainly target men. Follicum’s FOL-005 is a compound in clinical development that […]
BioStock published an article on 19 August 2020 about Follicum, which can be read in full below. Yesterday, Follicum announced that they have recruited over 50 per cent of the intended patient group for their ongoing phase IIa trial with the topical formulation of the hair growth stimulating candidate FOL-005. Thus, the study is well on […]
BioStock published an article on 25 June 2020 about Follicum, which can be read in full below. During the first half of 2020, Follicum has started, paused and resumed a phase II study with its primary candidate FOL-005. An international patent application has been filed regarding its newly developed topical formulation as a carrier of […]
BioStock published an article on 17 June 2020 about Follicum, which can be read in full below. Tomorrow, world-leading diabetes experts and front runners of regional R&D in type 1 diabetes will gather at a free Medicon Valley Alliance webinar. Lund-based Follicum will be among the participants, and BioStock has talked to CEO Jan Alenfall […]
BioStock published an article on 12 May 2020 about Follicum, which can be read in full below. The peptide specialist company Follicum has filed an international patent application for its topical cream formulation. The application is both relevant for the company’s furthest-advanced candidate, FOL-005, which is currently undergoing a clinical phase IIa study in hair […]
BioStock published an article on 27 April 2020 about hair loss and Follicum, which can be read in full below. Hair loss is a benign condition with limited physical effects, but the psychosocial aspects are more severe. Hair is a key part of our self-image and self-expression, aspects that can be ruthlessly squashed by hair […]
BioStock published an article on 25 March 2020 about Follicum, which can be read in full below. Follicum’s diabetes project took a big leap forward last Friday with a preliminary patent approval from the European Patent Office regarding the company’s diabetes peptides. BioStock contacted CEO Jan Alenfall to find out more about the project, the patent […]